1
60
1
1
| Cat. No. | Product Name | ||
|---|---|---|---|
| L1710 | 抗COVID-19化合物库 | 1160 compounds | |
| A unique collection of 1160 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents； | |||
| L6720 | 抗COVID-19中药单体库 | 1162 compounds | |
| A unique collection of 1162 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening； | |||
| L7870 | 可溶性羧酸片段化合物库 | 1807 compounds | |
| L2510 | 脂代谢化合物库 | 496 compounds | |
| A unique collection of 496 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS). | |||
| L3510 | 甲基化化合物库 | 131 compounds | |
| 131 methylation-related compounds that can be used for high-throughput and high-content screening. | |||
| L8720 | 细胞焦亡化合物库 | 1077 compounds | |
| 1077 types of active small molecules associated with pyroptosis for high-throughput and high-content screening. | |||
| CL0132 | DHFR inhibitor kit | ||
| L9230 | ReFRAME 相关化合物库 | 3274 compounds | |
| A unique collection of 3274 compounds for high-throughput screening and high-content screening, | |||
| L6700 | 抗癌天然产物库 | 1800 compounds | |
| A unique collection of 1800 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
| L1380 | 转录因子库 | 704 compounds | |
| Well-chosen 704 compounds with unique structures targeting transcription factor; | |||
| L2152 | 靶向治疗药物库 | 121 compounds | |
| 121 tumor-targeted drugs that can be used for high-throughput and high-content screening. | |||
| L9830 | 抗帕金森病化合物库 | 908 compounds | |
| A unique collection of 908 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS. | |||
| L7000 | 活性脂质化合物库 | 385 compounds | |
| A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsa | |||
| L2570 | 人代谢物化合物库 | 4532 compounds | |
| A unique collection of 4532 human metabolites for high-throughput, high-content screening. | |||
| CL0065 | Antifungal compound kit | ||
| L4700 | 免疫/炎症分子化合物库 | 3483 compounds | |
| A unique collection of 3483 anti-inflammation compounds effective for high throughput screening and high content screening. | |||
| L4150 | 新颖已知活性精选库 | 990 compounds | |
| It is well-selected from Bioactive compound library Plus (D7800), from which 1-15 compounds with the highest scores (activity value, pharmacological properties, structure-diversity, etc.) were chosen. This library consists of 990 compounds without compro | |||
| VM1400 | 多样性核心库Part2 | ||
| L6130 | 萜类天然产物库 | 349 compounds | |
| A unique collection of 349 natural terpenes and terpenoids can be used for high throughput and high content screening； | |||
| CL0046 | 5-HT Receptor antagonist/agonist kit | ||
| L2500 | 人内源代谢化合物库 | 1400 compounds | |
| A unique collection of 1400 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening; | |||
| L2550 | 谷氨酰胺代谢化合物库 | 580 compounds | |
| A unique collection of 580 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and cancer; | |||
| CL0150 | DNA Methyltransferase/Demethylase inhibitor kit | ||
| CL0128 | HMGCR inhibitor kit | ||
| L1720 | 核苷类化合物库 | 337 compounds | |
| A unique collection of 337 nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs; | |||
| L4520 | 抗菌活性库 | 921 compounds | |
| A unique collection of 921 antibacterial bioactive compounds, a powerful tool for antibacterial drug development; | |||
| CL0141 | Notch pathway inhibitor kit | ||
| CL0131 | SGLT inhibitor kit | ||
| CL0136 | ATM/ATR inhibitor kit | ||
| CL0047 | AChR antagonist/agonist kit | ||
| L4400 | 抗生素库 | 708 compounds | |
| A unique collection of 708 compounds with antibiotic activity for new antibacterial drug screening; | |||
| L3980 | DNA损伤/修复库Plus | 667 compounds | |
| Well-chosen 667 compounds with unique structures targeting DNA damage & repair; | |||
| CL0144 | Endothelin Receptor antagonist kit | ||
| NY1000 | 天然产物衍生物库 | 4000 compounds | |
| The library consists of more than 4,000 members belonging 22 scaffolds (average 180 compounds per scaffold). | |||
| L2192 | 抗胰腺癌化合物库 | 2267 compounds | |
| A unique collection of 2267 pancreatic cancer related compounds can be used in HTS and HCS; | |||
| L2400 | 内分泌激素分子库 | 813 compounds | |
| A unique collection of 813 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L8710 | 铜死亡化合物库 | 411 compounds | |
| TargetMol’s Cuproptosis Compound Library is a collection of 411 compounds related to copper-dependent death that can be used to study its mechanism and related diseases. | |||
| L5100 | 含氟化合物库 | 583 compounds | |
| A unique collection of 583 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS); | |||
| L9700 | 内质网应激化合物库 | 193 compounds | |
| A unique collection of 193 endoplasmic reticulum stress (ER stress) related compounds used for high throughput screening (HTS) and high content screening (HCS); | |||
| L6030 | 天然产物衍生物虚筛化合物库 | ||
| L2800 | 5-羟色胺分子库 | 275 compounds | |
| A unique collection of 275 compounds targeting serotonin receptors for high throughput screening and high content screening; | |||
| L6100 | 天然多酚类化合物库 | 640 compounds | |
| A unique collection of 640 natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L1510 | 核受体化合物库 | 420 compounds | |
| A unique collection of 420 nuclear receptor signaling targeted compounds for high throughput and high content screening; | |||
| L2140 | 癌细胞分化化合物库 | 413 compounds | |
| A unique collection of 413 cancer cell differentiation inducing compounds for high throughput and high content screening; | |||
| L3300 | 组胺&褪黑色素化合物库 | 155 compounds | |
| A unique collection of 155 compounds targeting histaminergic receptor and melatonin receptor for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L1600 | 激酶抑制剂库 | 2230 compounds | |
| A unique collection of 2230 kinase inhibitors for high throughput screening and high content screening for drug discovery in kinase related diseases; | |||
| L2620 | 神经退行性疾病化合物库 | 1622 compounds | |
| A unique collection of 1622 compounds related to neurodegenerative diseases can be used for HTS or HCS； | |||
| L2196 | 抗卵巢癌化合物库 | 1888 compounds | |
| L1120 | AMPK靶向分子库 | 64 compounds | |
| 64 well-chosen unique AMPK-targeted small molecules； | |||
| L6800 | 中国药典收录天然产物库 | 2070 compounds | |
| A unique collection of 2070 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study; | |||
| L2130 | 抗癌细胞代谢库 | 1280 compounds | |
| A unique collection of 1280 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS); | |||
| DF4500 | 多样性核心库Part1 | ||
| L6200 | 瑶药化合物库 | 225 compounds | |
| A collection of 225 natural product molecules originated from Yao medicine, which can be used for high-throughput and high-content screening. | |||
| L9600 | 多肽分子库 | 533 compounds | |
| 533 peptides can be used in peptide drug development and signaling transduction and mechanism study; | |||
| L6120 | 黄酮类天然产物库 | 477 compounds | |
| A unique collection of 477 flavonoids can be used for high throughput and high content screening； | |||
| L1100 | 蛋白酶抑制剂库 | 344 compounds | |
| A unique collection of 344 protease and proteasome inhibitors for research in chemical genomics, and drug screening; | |||
| L3800 | NF-κB 通路分子库 | 560 compounds | |
| A unique collection of 560 compounds targeting NF-κB signaling for high throughput screening and high content screening; | |||
| L7600 | 趋化因子抑制剂库 | 59 compounds | |
| A unique collection of 59 chemokines or chemokine receptors targeted compounds for high throughput and high content screening; | |||
| L8200 | 抗衰老化合物库 | 3324 compounds | |
| A unique collection of 3324 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L8500 | HIF-1化合物库 | 1352 compounds | |
| A unique collection of 1352 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies； | |||
| Cat. No. | Product Name | Form | Specificity Of Inhibition |
|---|---|---|---|
| C0003 |
Phosphatase Inhibitor Cocktail II (100× DMSO)
磷酸酶抑制剂 Cocktail II |
Solution (100× in DMSO) | Alkaline phosphatases, Ser/Thr phosphatases, <em><em>Acid</em></em> and PP1 and PP2A |
| Cat. No. | Product Name | ||
|---|---|---|---|
| EC3001 | TargetMol® 16 道磁力架 | ||
| Cat. No. | Product Name | Target | Signaling Pathways |
|---|---|---|---|
| T37258 | 13-methyl Myristic Acid methyl ester | ||
| 13-methyl Myristic acid methyl ester is a methylated bacterial fatty acid methyl ester. It has been used as a marker of bacteria in sewage sludges and of bacterial contaminants in pharmaceutical manufacturing by GC-MS. | |||
沪公网安备 31010602006700号
